`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ALEKHA K. DASH, R.Ph., Ph.D.
`CURRICULUM VITAE
`
`Vireo Systems, Inc. Ex. 2011 - 001
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CURRICULUM VITAE
`
`Name:
`
`Alekha K. Dash, R.P., Ph.D.
`
`Business Address:
`
`Home Address:
`
`Creighton University
`School of Pharmacy and
`Health Professions
`2500 California Plaza
`Omaha, NE 68178-0230
`Phone: (402) 280-3188
`Fax: (402) 280-1883
`adash@creighton.edu
`
`Personal Data:
`
`Citizenship:
`Date of Birth:
`Marital Status:
`
`Schools Attended:
`
`13518 Sahler Street
`Omaha, NE 68164
`
`Phone: (402) 492-9707
`
`US Citizen
`August 1st, 1954
`Married, two children
`
`(a) University of Minnesota, USA (September 1984 - December 1990).
`(b) Jadavpur University, Calcutta, India (July 1977 - August 1984).
`
`Degrees Earned:
`
`(a) Doctor of Philosophy (Ph.D.) in Pharmaceutics - December, 1990, University
`of Minnesota, USA.
`(b) Master of Pharmacy (M.Pharm.) in Pharmaceutics (First class First) - May,
`1983, Jadavpur University, India.
`(c) Bachelor of Pharmacy (B.Pharm.)(First class First with Hons.) - June, 1981,
`Jadavpur University, India.
`
`Professional License:
`
`(a) Registered Pharmacist, State of Nebraska, License #: 12239 (December 28,
`2004).
`
`
`
`
`Vireo Systems, Inc. Ex. 2011 - 002
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`Patents:
`Granted:
`1. Hydroxyapatite Based Drug Delivery Implant for Cancer Treatment;
`US Patent # 6767550, July 2004.
`2. Trademark registration (Reg. No. 3,687,057) on “NANOME™”.
`Registered on Sept 22, 2009.
`3. Mucoadhesive Nanoparticles For Cancer Treatment (A. Dash and W.
`Trickler) Filled on October 26, 2006. Issued US Patent 20100323977.
`Pending:
`1. Foam-Film System with Antibacterial Properties and Methods for
`Reducing Bacterial Contamination in Animal Carcasses, Filed on
`November 15, 2003. International Application #: PCT/US04/038094.
`
`Special Training Program:
`
`1. Classroom Communication Skills for Teaching Assistants, University of
`Minnesota, September 24, 1984-December 7, 1984.
`2. Workshop on Sexual Harassment, Creighton University, March 9, 1994.
`3. Certificate course on “Foundations of Effective Supervision”, Creighton
`University, September 15- December 7, 2004.
`4. eFellows, Creighton University, August 2005-May 2006.
`5. Special workshop on “Applications of Nanonobiology to Biodefense”,
`Rockville, MD, November 7-18, 2005.
`6. Academic Leadership Fellows Program, American Association of Colleges of
`Pharmacy, July 2008-June 2009.
`7. Academic Chair Coaching, Coaches: Alan T Seagren and Daniel W. Wheeler,
`University of Nebraska at Lincoln, January 2012- May 2013.
`
`Professional Employment:
`
`2014-present
`
`2008-present
`2007-Present
`
`Interim Associate Dean for Research, School of Pharmacy and
`Health Professions, Creighton University, Omaha, Nebraska.
`Gilbert F. Taffe, Jr. Endowed Chair of Pharmacy Sciences.
`Chair, Department of Pharmacy Sciences, Creighton
`University, Omaha, Nebraska.
`
`2004-2007
`
`Interim Chair, Department of Pharmacy Sciences, Creighton
`University, Omaha, Nebraska.
`
`2003-present
`
`Professor, Department of Pharmacy Sciences, Creighton
`University, Omaha, Nebraska.
`
`1995-2003
`
`Associate Professor with Tenure, Department of
`Pharmacy Sciences, Creighton University, Omaha, Nebraska.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Vireo Systems, Inc. Ex. 2011 - 003
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`1990-1995
`
`Assistant Professor, Department of Pharmaceutical and
`Administrative Sciences, Creighton University, Omaha,
`Nebraska.
`
`1994-present
`
`Adjunct Professor, Department of Pharmaceutical
`Sciences, University of Nebraska Medical Center, Omaha,
`Nebraska.
`
`1984-1990
`
`1984-1990
`
`1984-1990
`
`1982-1983
`
`1981-1982
`
`Teaching Assistant, Department of Pharmaceutics, University
`of Minnesota.
`
`Research Assistant, Department of Pharmaceutics, University
`of Minnesota.
`
`Pharmacy Technician, University of Minnesota Hospital and
`Clinics.
`
`Consultant, Pharmaceutical Division, Prasen Center, Calcutta,
`India.
`
`Manufacturing Supervisor, DUSAP Pharmaceuticals, Calcutta,
`India.
`
`
`Consultantship and Professional Services:
`
`(a) Consultant
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`USAID Consultant to Armenia, August 2013-Dec 2013
`
`Department of Pharmaceutics, Faculty of Pharmacy, Kuwait
`
`University, May 19-27, 2012, Kuwait City, Kuwait
`
`Palm Pharmaceuticals, Fremont, CA (2004-2006)
`
`Healthway Pharmacy Technology, MD, 2008-2010)
`
`Agouron Pharmaceutical Inc., San Diego, CA (1993-1998)
`
`Gattefosse, Inc., France (1996-2003)
`
`ConAgra, Inc, Omaha, NE (1996-2007)
`
`Eastern Nebraska Forensic Lab (1995-1998)
`
`Fortress Systems International, Omaha, NE (1998-2003)
`
`
`Vireo Systems, Inc. Ex. 2011 - 004
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`Berkeley Advanced Biomaterials, San Leandro, CA (1998-2000)
`
`Char/Hansen Ingredients, Mahwah, NJ (1999-2004)
`
`Rhodia, Inc, Cranbury, NJ (1999-2003)
`
`Technical Consultant and Expert Services for Various Law Firms on
`Patent & Pharmaceutical Litigation Cases (1995-present).
`
`(b) Chair, AAPS Preformulation Focus Group (2004-2005).
`(c) Chair, AAPS (APQ section) Awards Committee (2006-2010)
`(d) Member, International Advisory Committee on Nanomedicine-2007
`conference, BBSR, Orissa, India, February 23-25, 2007.
`(e) AAPS, Pharmaceutical Technology, Planning Committee (2004-2006).
`(f) Member of the Editorial Board, Current Pharmaceutical Analysis (2004-
`Present).
`(g) Chair and Organizer of the New Drug Delivery Systems Section of the 1995,
`1996 and 1997 Cells and Materials Meeting.
`(h) Member of the Editorial Board, Analytical Profiles of Drug Substances and
`Excipients (1995-Present).
`(i) External Reviewer and Ph.D. Thesis examiner for Jadavpur University,
`Calcutta, India.
`(j) External Reviewer and Ph.D. Thesis examiner for Birla Institute of
`Technology, Mesra, Ranchi, India.
`(k) Chair and Organizer of the Drug Delivery Systems Section of the 1996 Fine
`Particle Society Meeting.
`(l) Member of the Editorial Board, Journal of Drug Delivery (2010-Present).
`(m) Member of On-site Evaluation Team for Accreditation Council for Pharmacy
`Education (2007-present).
`(n) Reviewer for NIH Study Section: National Cancer Institute Special Emphasis
`Panel: Innovative Methods: Manufacturing Cancer Therapeutics (ZCA1
`SRRB-D (C1) February 26, 2009).
`(o) Reviewer for City University of Hong Kong Strategic Research Grant, 2012;
`February 27, 2012.
`(p) Member of the Editorial Board, International Journal of Pharmacology and
`Toxicology (2013-Present).
`(q) External Reviewer and Ph.D. Thesis examiner for Guru Nanak Dev University,
`Amritsar, India.
`(r) Member of the Editorial Board, OA Drug Design & Delivery (2013-Present).
`(s) Member of the Editorial Board, Current Protein and Peptide Science
`(2009-Present).
`
`Professional Organizations:
`
`
`
`
`
`
`
`
`Vireo Systems, Inc. Ex. 2011 - 005
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`(a) Member, American Association of Pharmaceutical Scientists (1991-Present).
`(b) Member, American Association of Colleges of Pharmacy (1990-Present).
`(c) Member, American Association for the Advancement of Science (1994-
`Present).
`(d) Member, The New York Academy of Sciences (1995-Present).
`(e) Member, International Association of Dental Research (2004-present).
`(f) Member, Nebraska Pharmacist’s Association (2004-present).
`
`
`
`Fellowships and Honors:
`
`2013
`2012
`2008-2009
`
`Visiting Professor, MISR International University, Cairo, Egypt.
`Fellow, American Association of Pharmaceutical Scientists
`Academic Leadership Fellow, American Association of
`Colleges of Pharmacy
`Holder of Gilbert F. Taffe, Jr. Endowed Chair of Pharmacy
`Sciences.
`Appointed as an eFellow for Academic Development and
`Technology Center, Creighton University.
`Fellow, University of Nebraska Graduate Faculty.
`2000 Outstanding Scientists of the 21st Century, International
`Biographical Center, Cambridge, England.
`Man of the Year, Nominated by the American Autobiographical
`Institute.
`Visiting Professor, University of Technology, Jamaica, West
`Indies.
`Who's Who in the World, in America, and in Science and
`Engineering.
`1995, 2000, 2005 Who's Who Among Americas Teachers.
`1994-present
`Adjunct Assistant Professor, Department of Pharmaceutical
`Sciences, University of Nebraska Medical Center, Omaha,
`Nebraska.
`Member of the Creighton Graduate Faculty.
`Member of Phi Beta Delta Honor Society for International
`Scholars.
`Recipient of the Pharmaceutical Research and Manufacturers
`Association Undergraduate Research Fellowship in
`Pharmaceutics.
`Recipient of PMA (Pharmaceutical Manufacturers Association,
`USA) Visiting Professor for 1993 Award: Sponsored by
`Berlex Laboratories, Wayne, NJ (August 1-8).
`International Students Work Opportunity Program
`Fellowship (ISWOP), University of Minnesota.
`Member of Rho Chi Honor Society.
`
`2008-present
`
`2005-2006
`
`2002-present
`2000
`
`2000
`
`1997
`
`1995-present
`
`1994-present
`1994-present
`
`1993, 1999,
`and 2001
`
`1993
`
`1987-1990
`
`1986-present
`
`Vireo Systems, Inc. Ex. 2011 - 006
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`1985-1988
`
`Samuel Melendy Fellowship, University of Minnesota.
`
`
`
`
`
`
`
`Awards:
`
`2012
`
`2007
`
`2007
`
`2006
`
`2005
`
`2004
`
`2000
`1997-98
`
`1997-98
`
`1996-97
`
`1996-97
`
`1996-97
`
`1996
`
`1994 and 1995
`
`1993
`
`1993
`
`1991
`
`1983
`
`1981
`
`Nominated for the University Research Award, Creighton
`University.
`Nominated for the Robert F. Kennedy Memorial Award for
`Teaching Achievement, Creighton University.
`Nominated for the Teachers of Tomorrow Award, Omicron
`Delta Kapa, Creighton University.
`Special Citation for Exceptional Volunteer Service Award,
`American Red Cross-Heartland Chapter 2005-2006.
`Nominated for the Robert F. Kennedy Memorial Award for
`Teaching Achievement, Creighton University.
`Nominated for the Robert F. Kennedy Memorial Award for
`Teaching Achievement, Creighton University.
`Nominated for the AAPS Outstanding Educator Award.
`Scholarly Achievement Award, Department of Pharmaceutical
`& Administrative Sciences, Creighton University.
`Certificate of Recognition for Excellence in Teaching,
`Department of Pharmaceutical & Administrative Sciences,
`Creighton University.
`Excellence in Teaching Award, Creighton University, School of
`Pharmacy and Allied Health Professions.
`Scholarly Achievement Award, Department of Pharmaceutical
`& Administrative Sciences, Creighton University.
`Certificate of Recognition for Excellence in Teaching,
`Department of Pharmaceutical & Administrative Sciences,
`Creighton University.
`Member Phi Lambda Sigma National Pharmacy Leadership
`Society.
`Recipient of the Presidential Travel Scholarship from the
`Scanning Electron Microscopy International, Chicago, IL.
`Recipient of the John C. Kenefick Faculty Development
`Award, Creighton University.
`Outstanding Teacher of the Year: Nominated by the First Year
`Pharmacy Class (1992-1993).
`Recipient of the John C. Kenefick Faculty Development
`Award, Creighton University.
`The following Awards for securing the First Rank in the
`M.Pharm. program: University Medal and A. Sengupta
`Memorial Award.
`The following awards for securing the First Rank in the
`
`Vireo Systems, Inc. Ex. 2011 - 007
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`B.Pharm. program: IDMA G. P. Nair Gold Medal, University
`Medal and P. Das Memorial Award.
`
`Grants and Contracts:
`
`(A) Funded:
`
`(1) Dash, A. K. Creighton University Health Sciences Equipment Grant, 1991,
`$17,500.
`(2) Dash, A. K. The Health Future Foundation Faculty Development Grant,
`"Development of an Optimal Rectal Delivery System for Valproic Acid,"
`1991, $9,000.
`(3) Dash, A. K. and Noble, G. C. APQ Undergraduate Award in Pharmaceutical
`Analysis, "Development of a Nondestructive Method for the Analysis of
`Drugs in Microcapsule Formulations," 1992, $4,000 ($3,500 Grant + $500
`Travel Money).
`(4) Dash, A. K. PMA Undergraduate Research Fellowships in Pharmaceutics
`for student Steve D. Junker, "Effects of Lyophilization on the Physical State
`and Release Characteristics of Drugs in Microcapsule Formulations," 1993,
`$5,000.
`(5) Dash, A. K. The Health Future Foundation Faculty Development Grant,
`"Development of a Bioadhesive Rectal Delivery System for the Treatment of
`Ulcerative Colitis," 1993, $9,850.
`(6) Dash, A. K. Agouron Pharmaceuticals, "Evaluation of the In Vitro
`Dissolution Characteristics of Some Novel Oral Dosage Forms," 1993,
`$3,200.
`(7) Dash, A. K., Presidential Travel Scholarship from Scanning Electron
`Microscopy International, Chicago, IL. to attend the Cells and Materials
`1994 Meeting May 7 to May 14, Toronto, Canada, $500.
`(8) Dash, A. K. and Haney, P. W., APQ Undergraduate Award in
`Pharmaceutical Analysis, "Development of an In Vitro Dissolution Method
`Using Microdialysis Sampling Technique for Implantable Dosage Forms,"
`1994, $4,000.
`(9) Dash, A. K. Agouron Pharmaceuticals, "Solid-State Properties of AG337, a
`Novel Antitumor Drug," 1995, $3,380.
`(10) Dash, A. K., Presidential Travel Scholarship from Scanning Electron
`Microscopy International, Chicago, IL. to attend the Cells and Materials
`1995 Meeting May 6 to May 11, Houston, Texas, $300.
`(11) Dash, A. K. and Moster, D. K. (Ohio Northern University, Ada, Ohio), APQ
`Undergraduate Award in Pharmaceutical Analysis, "Utilization of
`Thermoanalytical Methods for the Quantitation of Moisture Absorption by
`Pharmaceutical Solids," 1995, $3,500.
`(12) Dash, A. K., American Heart Association Student Research Fellowship, “A
`
`Vireo Systems, Inc. Ex. 2011 - 008
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`Novel Approach to Treat Bone Cancer and to Minimize the Cardiac Toxicity
`of Anticancer Drugs,” 1996, $1,500. Student: Edward M. DeSimone III.
`(13) Dash, A. K., Grant from Gattefosse Incorporation, “Bioadhesive Rectal
`Nicotine Delivery System for Ulcerative Colitis,” 1996, $11,640.
`(14) Dash, A. K., State of Nebraska Smoking Grant (LB595), “Development of a
`Rapid Nasal Delivery Systems for Nicotine Replacement Therapy for
`Smoking Cessation,” 1996, $15,591.
`(15) Dash, A.K., Grant from ConAgra, “Development of a Novel Dosage Form
`for Probiotics,” 1996, $9,120.
`(16) Dash, A.K., Grant from ConAgra, “Microencapsulation of Some Food
`Products Undergoing Oxidative Degradation,” 1997, $4,200.
`(17) Dash, A.K., Grant from SK&B, “Effect of Sugar and Non-Sugars Additives
`on the Absorption of Calcium from Tums® Formulation,” 1996, $9,440.
`(18) Destache C. J., Pakiz, C.B., Dash, A.K., Larsen, C., and Meschter, C.,
`Society of Infectious Diseases Pharmacists, “Nitric Oxide Concentration in
`S. Pneumoniae Meningitis: Corelations with Cytopathy,” 1996-1997,
`$14,950. Co-investigator.
`(19) Dash, A.K., Grant from ConAgra, “Stability of Probiotic Formulations,”
`1998, $3,720.
`(20) Destache C.J., Pakiz, C.B., Dash, A.K., Larsen, C., Ortho-McNeil,
`“Pharmacokinetics of Levofloxacinin an Experimental Rabbit Meningitis
`Model With Penicillin Sensitive Pneumococci,” 1997-1998, $48, 855. Co-
`investigator.
`(21) Dash, A. K. and Owens, H., APQ Undergraduate Award in Pharmaceutical
`Analysis, “BBB Permeability Characteristics of Ceftrioxone and
`Levofloxacin in Rabbit Meningitis Model," 1998, $1,500.
`(22) Dash, A. K. PMA Undergraduate Research Fellowships in Pharmaceutics
`for Student Heather Owens, "Study of the BBB Permeability Characteristics
`of antibiotics in Rabbit Meningitis Model," 1999, $5,000.
`(23) Dash, A.K., Grant from Gattafosse Inc., “In vivo Evaluation of the
`Bioadhesive Nicotine Suppository in Ulcerative Colitis,” $4,000.
`(24) Dash, A.K., Grant from Fortress Inc., 1999, “Evaluation of the Solid-State
`Properties and Oral Bioavailability of Creatine Monohydrate,” $10,960.
`(25) Dash, A. K., Grant from Depomed Inc., 1999. “Functional Absorption of
`Calcium from a Gastric Retained Tablet,” $10,940.
`(26) Dash, A. K., Grant from Rhodia Inc., 1999. “Formulation of Radiolabeled
`A-Tab and Di-Tab Tablets for Oral Absorption Studies,” $15,500.
`(27) Dash, A. K., Grant from CHR. Hansen Ingredient Inc., 1999. “Development
`of Quick Release Calcium Carbonate Formulation,” $4,800.
`(28) Dash, A.K. and Mo, YoonSun, “Solid-State Properties of Creatine
`Monohydrate,” AFPE Gateway Fellowship, 2000, $5,000.
`(29) Dash, A.K. “Use of Maltodextrin and Calcium Carbonate in the Formulation
`
`Vireo Systems, Inc. Ex. 2011 - 009
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`of Tablet Dosage Forms for Natural Products,” Char/Hansen, 2000, $3,500.
`(30) Dash, A. K. “Evaluation of the Stability of a Natural Antiseptic
`Formulation,” ConAgra Inc., 2000, $1,800.
`(31) Dash, A. K. Creighton University School of Pharmacy and AHP Equipment
`Grant, 2000, $18,000.
`(32) Dash, A K., Received an instrument grant worth $25,000 from Alza Inc.,
`Minneapolis, MN, May 2000 (Spectrophotometer and HP Series HPLC).
`(33) Dash, A. K. PMA Undergraduate Research Fellowships in Pharmaceutics
`Project Title: “A Novel Drug Delivery System for the Targeted Local
`Delivery of Doxorubicin.” Student: John Okogbaa, 2001, $5,000.
`(34) Dash, A.K., “Utilization of Direct Compressed Honey and Molasses in
`Masking the Unpleasant Taste and Odor of Some Herbal Products,”
`Char/Hansen, 2001, $7,900.
`(35) Ohia, S. and Dash, A. K., “Hydrogen Peroxide and Retinal Neurotransmitter
`Release,” Academic Research Enhancement Awards (AREA), 2000,
`$141,000 (Co-Investigator).
`(36) Dash, A. K., Grant from Rhodia Inc., 2001. “Use of A-Tab and Di-Tab in
`Nutraceutical Formulations,” $7,290.
`(37) Dash, A.K. “Quantitation of Ephedrine and Caffeine in Dietary Supplement
`Formulations,” AdvoCare International, Carrollton, TX, 2001, $5,000.
`(38) Dash, A.K. ConAgra Inc., 2001, “Formulation of a Sustagrain Chewable
`Tablet Formulation,” $2,600.
`(39) Dash, A.K. Summer Minority High School Students Research Grant $500
`(2002).
`(40) Dash, A.K. Summer Minority Student Research grants $400 (2002).
`(41) Saini T. and Dash, A. K. (Co-investigator), “Development of Novel
`Polyantibiotic Local Delivery System for Intracervicular Medication,” HFF
`Foundation, Omaha, NE, $18,840, 2002.
`(42) Opere, C., Ohia, S. and Dash, A.K. (Consultant) “Effect of Isoprostanes on
`Retinal Transmitter Release.” Amount: HFF Foundation, Omaha, NE,
`$20,000, July 1, 2002 to June 30, 2004.
`(43) Dash, A.K. ConAgra Inc., 2002, “Chewable Tablet Formulations Using
`Natural Fiber,” $11,600.
`(44) Dash A.K. and D. Cadaoas, “Development of a Polyantibiotic Local Drug
`Delivery System for Intracrevicular Medication,” 2004 AFPE Gateway
`Research Scholarship, $5,000.
`(45) Dash, A.K. Summer Minority High School Students Research Grant $500
`(2004).
`(46) Dash, A.K. Summer Minority Student Research grants $400 (2004).
`(47) Dash, A.K., “Preformulation and Formulation Development for a Novel
`Radioprotectant: ON1210.Na,” Palm Pharmaceuticals, 2004-present,
`$34,000.
`(48) Dash A. K. (Co-PI) and P. Silberstine (PI), “Bioavailability of Transdermal
`
`Vireo Systems, Inc. Ex. 2011 - 010
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`ABH and BDH Gel, HFF,” 2004-present, $6,000.
`(49) Barr, C. (PI) and Dash, A.K. (Co-PI), “Challenges Associated with National
`Pharmaceutical Stockpile to Respond to a Terrorist Event and Some Viable
`Alternative,” SPAHP Faculty Research Development Grant, 2004-2005,
`12,880.
`(50) Destache, C. (PI) and Dash, A.K. (Co-PI), “Delivery of Proteins to the Brain
`Using Nanotechnology for Neuroprotection,” SPAHP Faculty Research
`Development Grant, 2004-2005, 14,940.
`(51) Gross, S (PI), Singh, S. (Co-Investigator) and Dash, A. K. (Co-Investigator),
`Acquisition of a State of the Art Gel Permeation Chromatographic System.”
`U. S. Department of Defense, May 1 2005- April 30, 2006, $69,989.
`(52) Dash, A.K.(PI), “A Novel In Situ Gel Drug Delivery System for Breast
`Cancer Treatment,” Department of Defense, Grant # BC045664, $106,875
`(2005).
`(53) Dash, A.K. and Murthy, Gowri, “A Novel Mucoadhesive Gel Delivery
`System for the Treatment of Breast Cancer,” AFPE Gateway to Research
`Fellowship, 2006, $5,000.
`(54) Dash, A.K., “Stability Evaluation of a Novel Radioprotectant: ON1210.Na
`in Suspension Formulation,” Palm Pharmaceuticals, April-July, 2006,
`$2,500.
`(55) Dash, A.K.” Preliminary Evolutions of Methyl-glyoxal”, Healthway
`Pharmacy, 2008, $17,500
`(56) Dash A.K. (CO-PI) and Destache C. (PI), NIH-AREA, Pharmacology of
`Antiretroviral Nanoparticle Micelles, 2008, $282,348.
`(57) Dash A.K., United States Pharmacopeia Grant offering for Pharmacy
`Compounding, Group A, 2008, $30,000.
`(58) Dash, A.K., Health Future Foundation, Omaha, NE, Instrument grant,
`$150,000.
`(59) Dash, A.K., Thermolife International, Creatine Nitrate solubility and
`stability, December 2009-June 2010, $14,575.
`(60) Dash, A.K., LB 692 New Initiatives Research Grant Program, State of
`Nebraska Cancer & Smoking Grant, Nanome™: A Novel Nanodelivery
`System for Tumor Targeting, July 2010-June 2011, $99,036.
`(61) Dash, A.K., Propst, S., Student Research Program SPAHP 2011,
`Multifunctional Nanoparticle Formulation and Characterization for Lung
`Cancer Treatment, August 2010- May 2012, $3,000.
`(62) Dash, A.K., President’s Faculty Research Fund, Novel Skin-bound
`Melanoidinns-Sunscreen a Delivery Approach to Melanoma Prevention,
`February 15, 2012-February 14, 2013, $10,000.
`(63) Dash, A.K. (CO-PI) and Govindarajan V., PMP: Biologic Foundations
`for New Treatment Option, National Organization of Rare Disorders
`(NORD), February 1, 2014-January 31, 2015, $25,000.
`
`Vireo Systems, Inc. Ex. 2011 - 011
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`(64) Dash, A.K., Use of Pharmaceutics in the Development of Pet Care
`Products, Sergent’s Pet Care Products Co., December 1, 2013-
`December 31, 2014, $6,312.50.
`(65) Dash, A.K., Evaluation of Vacuant vs Enemeez, Alliance Labs LLC,
`December 1, 2013-December 31, 2014, $4,563.
`(66) Dash, A.K., Evaluation of Various Chewable Tablet Formulations,
`Fitzpatrick, Cella, Harper & Scinto, December 1, 2013-December 31,
`2014, $4,812.03.
`(67) Dash, A.K., Evaluation of Creatine Permeability Studies, Phenolics
`LLC, Omaha, NE, February 2015-December 2015, $10,500.
`(68) Dash, A.K. (Co-PI) and Venkatesh Govindarajan (PI), Acquired Resistance
`to Targeted Therapy in Mucinous Colorectal Cancers. LB595 Grant, July 1
`2015- June 30, 2017, $95,000.
`
`
`
`
`
`
`
`
`
`
`
`(B) Approved but not funded:
`
`(1) Dash, A. K., "Biodegradable Doxorubicin Delivery Systems to Treat Bone
`Cancer," Cancer and Smoking Disease Grant 1995, State of Nebraska.
`Amount Requested: $29,850.
`(2) Dash, A. K., "Development of Rapid Nasal Delivery System for Nicotine
`Replacement Therapy for Smoking Cessation," Cancer and Smoking
`Disease Grant 1995, State of Nebraska.
`Amount Requested: $29,700.
`(3) NSF RII (EPSCoR) Preproposal "Engineering Nanomanufacturing for
`Biomedical Applications," PI/PD: Y. Dzenis, UNL, Requested from NSF -
`PIs: UNL: Dzenis, Turner, Zeng, Feng, Farritor, Subramanian,
`Larsen, Viljoen, Rajurkar UNMC: Kabanov, Creighton: Dash, Gross,
`Amount Requested: $2,000,000 (2006-2009).
`(4) Dash, A.K., “Surface Modified Nanoparticles for Radioprotectant
`Delivery and Therapy,” NIH (1 R21 AI071255-01).
`Amount Requested: $406,856 (2006-2009).
`(5) A.K. Dash (PI) and P.T. Silberstein (CO-PI), T. Saini (CO-PI), D.A.
`Dobberpuhl (CO-PI), “High Sensitivity LC-MS System in Nano- Delivery
`System Design and Radioprotectant Research,” Department of Defense,
`DURIP Proposal, Amount Requested: $182,656.
`(6) Dash, A.K., “Surface Modified Mucoadhesive Nano-Delivery System for
`Breast Cancer Treatment.” Amount Requested: $107,625 (2008-2009)
`
`
`
`Graduate and Honors Student Theses:
`
`1.
`
`External Examiner (2006) for the Ph.D. Thesis of Mr. Subir Samanta
`(Title: “Symthesis and Studies of Piperidine Analogues,” Birla Institute
`
`Vireo Systems, Inc. Ex. 2011 - 012
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`2.
`
`3.
`
`of Technology, Mesra, Ranchi, India).
`External Examiner (1995) for the Ph.D. Thesis of Mrs. Sutapa Sardar
`(Title: “Antitumor Potential of Vitamin D3 on Murine Lymphoma and its
`Role in the Inhibition of Tumourigenesis,” Jadavpur University, Calcutta,
`India).
`External Examiner (1997) for the Ph.D. Thesis of Mr. P. Suresh
`(Title: “Design and Evaluation of Transdermal Drug Delivery
`Systems,” Jadavpur University, Calcutta, India).
`4. Master Thesis Advisor: Heather Owens (Title: “Development of
`Analytical Methods for the Assay of Ceftrioxone and Levofloxaxin in
`Rabbit Plasma”).
`5. Master Thesis Advisor: Nai Yun Fan (Title: “Development of an
`Implantable Doxorubicin Delivery System for the Treatment of Bone
`Cancer”).
`6. Master Thesis Advisor: YoonSun Mo (Title: “Solid-State
`Characterization of Creatine Monohydrate and its Oral
`Bioavailability”).
`7. Master Thesis Advisor: Nguyen Chinh (Title: “Evaluation of the
`Absorption Characteristics of Nicotine from Rectal Suppository
`Formulations in a Rabbit Model”).
`Ph.D. Committee member for Angela M. LeDay, Department of
`Pharmacology, Creighton University.
`External Examiner (2002) for the Ph.D. Thesis of Mr. V. Suba (Title:
`“Phytochemical and Pharmacological Evaluation of Barleria Lupulina
`Lindl.” (Family-Acanthaceae), Jadavpur University, Calcutta, India).
`10. External Examiner (2004) for the Ph.D. Thesis of Mr. M. Ganesan
`(Title: “Coated Pellets of Terbutaline: Development, Characterization,
`and Statistical Optimization by Response Surface Methodology,”
`Jadavpur University, Calcutta, India).
`11. Master Thesis Advisor: Sudipta Ganguly (Title: “A Novel In Situ Gel
`for Sustained Drug Delivery and Targeting,” 2003).
`12. Master Thesis Advisor: Saurabh Jauhari (Title: “In Situ Gel Delivery
`System for Paclitaxel”). Submitted October, 2006.
`13. Ph.D. Examination Committee member for Aaron Mayo, UNMC,
`2005-2007.
`14. Master Thesis Advisor: Kanishka Pathak (Title: “Drug Delivery
`System Design for Dental Cavities”)-2007.
`15. Master Thesis Advisor: Divya Samineni (Title: “In vitro Evaluation of
`Antiemetic Topical Gels in Cancer Chemotherapy”) August, 2007.
`16. Master Thesis Advisor: Parina Fernandes (Title: “Preformulation and
`Formulation Development of a Novel Radioprotectant Drug”)
`October, 2007.
`17. Master Thesis Advisor: Ankita Nagvekar (Title: “Development and
`
`8.
`
`9.
`
`Vireo Systems, Inc. Ex. 2011 - 013
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`Characterization of Nanoparticulate Delivery System for the
`Radioprotectant Drug Amifostine). May, 2008.
`18. Master Thesis Advisor: Neha Jain (Title: “Preparation and
`Characterization of Amifostine and Melatonin Nanoparticle for
`Radioprotective Therapy). August, 2009.
`19. Master Thesis Advisor: Jatin Khurana (Title: “Development and
`
`Characterization of Polymeric Nanoparticulate Delivery System for
`Hydrophilic Drug: Gemcitabine). December, 2009.
`
`20. External Examiner (2006) for the Ph.D. Thesis of Mrs. Chitrali
`Mallikarjuna Setty (Title: “Development and Evaluation of Novel
`Microparticulate Drug Delivery Systems Using Natural Polymers,”
`Jadavpur University, Calcutta, India).
`21. External Examiner (2007-2008) for the Ph.D. Thesis of Mr. Durga
`Madhab Kar (Title: “Synthesis and Pharmacological Studies of Some
`Nitrogen Heterocyclic Compounds with Special Interest on Indole
`Derivatives,” Birla Institute of Technology, Mesra, Ranchi, India).
`22. External Examiner (2010) for the Ph.D. Thesis of Mr. Animesh Ghosh
`(Title: “Biopharmaceutical Evaluation of Fixede Dose Combination of Anti
`Diabetic Drugs,” Jadavpur University, Calcutta, India).
`23. External Examiner (2010) for the Ph.D. Thesis of Mr. Chirag Goda (Title:
`“Studies on Modern Drug Delivery Formulations of Potential Anti-Cancer
`Herbal Products”, Guru Nanak Dev University, Amritsar, India).
`24. Master Thesis Advisor: Ambrish Pandit (Title: Solid Lipid
`
`Nanoparticulate Formulation for Ifosfamide: Development and
`
`Characterization). February, 2011.
`25. Master Thesis Advisor: Pinal Mistry (Title: Surface Modified Solid
`
`Lipid Curcumin Nanoparticles for Oral Delivery). August, 2011.
`26. Master Thesis Advisor: Manas P. Gupte (Title: Preparation and
`Characterization of Methyl Glyoxal Nanoparticulate Drug Delivery
`System). August, 2011.
`27. Master Thesis Advisor: Sneha Dhapare (Title: Multifunctional
`Nanoparticles Containing Hydrophobic and Hydrophilic Drugs for
`Anticancer Drug Delivery). July, 2013.
`28. Master Thesis Advisor: Shantanu Chandratre (Title: Multifunctional
`Nanoparticles for Cancer Therapy). February, 2014.
`29. External Examiner (2014) for the Ph.D. Thesis of Mr. Bopi Gorain (Title:
`“An Approach to Improve Oral Bioavailability of Poorly Water Soluble
`Drug Based on Nanoemulsification Technique,” Jadavpur University,
`Kolkata, India).
`30. Master Thesis Advisor: Anne Grana (Title: Nanoemulsions in Topical Drug
`Delivery). November, 2014.
`31. External Examiner (2015) for the Ph.D. Thesis of Mr. B. Prathap (Title:
`“Method Development and Validation of Selected Drug in Formulations by
`
`Vireo Systems, Inc. Ex. 2011 - 014
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`
`
`
`
`
`
`
`
`Using Various Analytical Techniques,” Anamalai University, Tamilnadu,
`India).
`
`Services:
`
`(A) Department/School/University Services:
`
`1. Member - Pharmacy Continuing Education Committee (1992-1994,
`2000, 2001).
`2. Member - Pharmacy Awards Committee (1991-1992).
`3. Member - Pharmacy Accreditation Self-Study Steering Committee
`Student Service Sub-Committee, 1991).
`4. Member - Contemporary Practice Laboratory - ad hoc Committee
`(1991, 1995. 1996).
`5. Member - Annual Academic Activity Committee (1991).
`6.
`Organized the Dorsey Trip to Lincoln for P1 Class (1991-1994).
`7.
`Accompanied the P2 Students during the Lilly Trip to Indianapolis
`(1991).
`8. Member - Pharmacy Curriculum Committee (1993-1995, 1999).
`9.
`Represented the Department at the Meetings of the Chairs of
`Departments of Pharmaceutics at the AAPS Annual Meeting (1992-
`present).
`10. Chair, Graduate Program Admission Committee (1997-2003).
`11. Chair, Departmental Goal ad hoc Committee (1997).
`12. Member Admission Committee, School of Pharmacy (1997-1999).
`13. Member, Rank and Tenure Committee (1996).
`14. Member, Students Dismissal Hearing Board (1997-1999).
`15. Member, Academic Support and Review Committee (2000-present)
`16. Member, Executive Committee (1996-1998).
`17. Chair - Pharmacy Accreditation Self-Study Steering Committee
`(Physical Facilities) 1998.
`18. Member, University Committee on Faculty Dismissals (1998).
`19. Member, University Long-Range Strategic Planning Committee on
`Leadership Training (1998-99).
`20. Member, Elected to University Faculty Council (1999-2001).
`21. Member, Executive Committee of University Academic Council
`(1999-2000).
`22. Represented the School at the 2000 AACP Institute, May 19-23, 2000,
`Xerox Documentary University, Leesburg, Virginia.
`23. Coordinator for the AACP/AAPS Visiting Scientist Program (1997-
`present).
`24. Member, Creighton University Research Compliance Committee
`(2000-present).
`
`Vireo Systems, Inc. Ex. 2011 - 015
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`

`29.
`
`25. Serving as a mentor for R. Garis, Ph.D., Assistant Professor,
`Department Pharmacy Sciences (1999-2005).
`26. Served as a mentor for S. Jonnalagada, Ph.D., Assistant Professor,
`Department Pharmacy Sciences (2000-2003).
`27. Served as a mentor for Anthony Randolph, for the Summer Research
`Training Program for minority students (2000).
`28. Served as a mentor for George Okpalaeze, for the Summer Research
`Training Program for minority students (2001).
`Interim Chair, Department of Pharmacy Sciences, March 1, 2004-
`March 1 2007.
`30. Served as a mentor for Oludara Amole, for the Summer Research
`Training Program for minority students (2004).
`31. Served as a mentor for Abiola Kosoko, for the Summer Research
`
`Training Program for minority students (2004).
`32. Member, Export Control Task Force, Creighton University.
`33. Member, Health Sciences Research Committee (2003-2008).
`34. Member, Administrative Committee (2004-present).
`35. Member, Strategic Planning Committee (2004-2006).
`36. Co-Chair, Pharmacy Accreditation Self-Study Steering Committee
`
`(Faculty) (2004-2005